Looking at top Wall Street opinions, Abbott Laboratories (NYSE: ABT) has recently made its way into the research list of BofA/Merrill – signaling that their analyst’s rating adjustment is noteworthy. This stock was Reiterated to a rating of Buy in the eyes of BofA/Merrill, as reported on Thursday, February 7th, 2019. Another heavy-hitting research note was published by Citigroup on Wednesday January 2nd, 2019, with this firm downgrading ABT to an updated rating of Sell from its previous rating of Neutral. In the past six months and three months of trading, shares of Abbott Laboratories (ABT) have moved by 13.19% and 12.52%, respectively.

Brokerage Updates Related to Abbott Laboratories (ABT) Stock

This publicly-traded organization generated losses of -1.25% over the last 5 sessions. Right now, this stock is the subject of 21 analysts’ evaluations, who – on average – have given this company’s shares a Strong Buy rating. Not a single analyst have given an underperform rating, 1 has given a sell rating and 10 have given a rating of Buy or better. Based on the 21 stock market experts following this company, the average 12-month price target is $80.76. Moreover, individual price targets range between $76.00-$88.00. With its recent move to $82.00, we can see that these firms project this stock will gain by 32.60% in one year.

Updates from Abbott Laboratories (ABT) SEC Form 4

This particular company’s shares have garnered a lot of attention in recent days, as insiders are unloading their holdings while having generated a 0.30% rise since the beginning of the calendar year. A Senior Vice President at Abbott Laboratories (ABT) sold off some of its shares in a transaction that was finalized on Mar 20. Similarly, WHITE MILES D sold 76,069 shares of the organization’s stock at $78.55 apiece and racked up $5,974,989 in earnings from the sale. Now, WHITE MILES D holds 3,174,165 shares of the company following the exchange. A Chairman and CEO of the organization named WHITE MILES D, was engaged in a transaction that occurred on Mar 18 that managed to be worth $6,405,781 from the sale of 81,580 common shares at a price of $78.52 per individual share.

Abbott Laboratories (NYSE:ABT) Results in the Pipeline

The next scheduled release of financial results for Abbott Laboratories will be for the Dec-18 quarter. As it stands right now, market analysts are anticipating the per-share earnings for the three-month period will be $0.81. In the same vein, they expect sales for the quarter to amount to $7,816.24 million.

Now let’s turn to earnings surprise history: in the most recent quarter, the company reported about $7,765.00 million in revenue alongside EPS at $0.81. On average, the analyst projection was calling for $7,656.00 million with $0.75 per share in earnings, respectively. In the preceding quarter, this company’s revenue reached $7,767.00 million, with earnings per share ending up at $0.73.

Cabot Oil & Gas Corporation (NYSE:COG) experienced a gain of 0.85% from the closing price in the previous trading day. That boost the price to $27.30 per share, as observed on December 31st, 1969, at a time when the total trading volume reached 4,462,733 shares of stock – compared to the typical average of 5.68M shares per day (as recorded over the past three months). The consensus estimate for these shares has been shifted to $27.55.

Pricing Indications for Cabot Oil & Gas Corporation (COG)

This organization has had a price-to-earnings ratio of 22.16 in the last year. Meanwhile, it gained 25.51 from its observable 50-day simple moving average. Right at this moment, the per-share value is 12.51% higher than the mean per-share price over the last 200 days in the market.

Cabot Oil & Gas Corporation (NYSE:COG) In-Depth Brokerage Insights

We can see that a number of brokerage firms are putting their focus onto this stock. Out of this group, 0 have a sell rating, 3 have a Buy rating, 11 have an outperform rating, while 13 provided a Hold rating for these shares – thanks to data from Thomson Reuters I/B/E/S. Additionally, 2 have recommended that these shares are an Underperforming investment. The current consensus recommendation is at 2.50, based on information from Thomson Reuters.

COG Stock Value Potential

In trading activity as of late, this stock’s value was 24.28 up from its 200 day moving average, while also 7.21% up when compared against its 50-day simple moving average. Over the course of the past year of trading, the share price stuck in the range of $21.00-$36.00. The market value for the entire organization reached 11.40B. In the last trading session, the price ended the day at $27.07. The institutional holdings related to this organization account for 1.60%, and the Beta factor is now 0.62. This company’s RSI (Relative Strength Index) managed to hit 67.14.

Cabot Oil & Gas Corporation (NYSE:COG) Analyst Points of Focus

Cabot Oil & Gas Corporation (COG) has found itself inside of KeyBanc Capital Mkts’s research list, so their analyst rating adjustment is worth taking note of. This stock was Initiated to Sector Weight, by KeyBanc Capital Mkts, as garnered from a news report on Monday January 14th, 2019. An additional helpful research note was sent out by Jefferies’s on Monday January 7th, 2019. The brokerage decided to upgrade COG to Buy from its previous rating of Hold.